Catalytic antibodies represent a unique class of immunoglobulins that combine conventional antigen recognition with intrinsic enzymatic activity, facilitating the direct cleavage of specific molecular ...
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...
Plasmacytoid dendritic cells are principal players in the innate immune response to viruses. Although rare (less than 0.2% of circulating peripheral blood cells), they secrete over 3 pg of the potent ...
The go-ahead for Novartis’ oral treatment marks a new option for patients with spontaneous urticaria who remain symptomatic despite antihistamine therapy.
Saint Louis University's Department of Molecular Microbiology and Immunology (MMI) offers a graduate program in molecular and cellular virology and immunology leading to a Ph.D. degree. The program ...
(RTTNews) - Bristol Myers Squibb (BMY) and Bain Capital have announced the formation of a new independent biopharmaceutical company dedicated to developing innovative therapies for autoimmune diseases ...
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases HiFiBiO Therapeutics, a ...
National Institute of Immunology invites Ph.D. applications 2025-26; interdisciplinary research, online interviews, ...
When Robert Kennedy Jr. announced the cancellation of 22 projects related to mRNA vaccines and the end of new investments in ...
AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve litigation that challenged their plans to introduce copycat versions of Rinvoq, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback